Stock Events

Stock Events

Stoke Therapeutics (STOK) Q3 2024 Earnings

7AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-0.69

-0.61

-0.54

-0.46

Details

Expected EPS

-0.548052

Actual EPS

-0.46

Surprise EPS

0.09

Surprise Percent

+16.07%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.46 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.